Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohort

• Päätekijät: Dion Groothof (Tekijä), Naser B.N. Shehab (Tekijä), Nicole S. Erler (Tekijä), Adrian Post (Tekijä), Daan Kremer (Tekijä), Harmke A. Polinder‐Bos (Tekijä), Ron T. Gansevoort (Tekijä), Henk Groen (Tekijä), Robert A. Pol (Tekijä), Reinold O.B. Gans (Tekijä), Stephan J.L. Bakker (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2024-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Serum creatinine is used as initial test to derive eGFR and confirmatory testing with serum cystatin C is recommended when creatinine‐based eGFR is considered less accurate due to deviant muscle mass. Low muscle mass is associated with increased risk of premature mortality. Howev...